Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiseizure Medication in Acute Brain Injury Seizure Networks
NCT06081283Phase 4Terminated
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Nov 2023
- Primary completion
- Dec 2024
- Modality
- Allosteric Modulators, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of phenobarbital, levetiracetam, lacosamide, valproic acid, fosphenytoin in acute brain injury (TBI), sponsored by University of North Carolina at Chapel Hill. Started Nov 2023; status: terminated.
02
Drugs
phenobarbitallevetiracetamlacosamidevalproic acidfosphenytoin
03
Conditions
acute brain injury (TBI)
Beyond the preview
Go deeper on NCT06081283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06081283.